Neuroantigen-specific autoregulatory CD8+ T cells inhibit autoimmune demyelination through modulation of dendritic cell function

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Kashi, Venkatesh P ^a   Ortega, Sterling B ^a   Karandikar, Nitin J ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD8 COGNATE ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG; AUTOANTIGEN; CD86 PROTEIN, MOUSE; HLA ANTIGEN CLASS 2; IL10 PROTEIN, MOUSE; MOG PROTEIN, MOUSE;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; B220+ B LYMPHOCYTE; CD11B+ MONOCYTE; CD11C+ DENDRITIC CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; DENDRITIC CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MONOCYTE; MOUSE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN SPECIFIC CD8+ T LYMPHOCYTE; NONHUMAN; PROTEIN EXPRESSION; PROTEOLIPID PROTEIN SPECIFIC CD8+ T LYMPHOCYTE; ANIMAL; IMMUNOLOGY; MULTIPLE SCLEROSIS; PATHOLOGY;

ANIMALS; ANTIGENS, CD86; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-10; INTERLEUKIN-12; MICE; MULTIPLE SCLEROSIS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN;

EID: 84937826002     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105763     Document Type: Article

References (58)

1. Woodroofe MN, Bellamy AS, Feldmann M, Davison AN, Cuzner ML (1986) Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J Neurol Sci 74: 135-152. (Pubitemid 16097141)
2. Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, et al. (1986) Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol 19: 578-587. (Pubitemid 16085192)
3. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, et al. (2000) Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192: 393-404. (Pubitemid 30629164)
4. Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, et al. (2004) Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A 101: 2428-2433. (Pubitemid 38269328)
5. Jacobsen M, Cepok S, Quak E, Happel M, Gaber R, et al. (2002) Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 125: 538-550. (Pubitemid 34194409)
6. Huseby ES, Huseby PG, Shah S, Smith R, Stadinski BD (2012) Pathogenic CD8 T cells in multiple sclerosis and its experimental models. Front Immunol 3: 64.
7. Zozulya AL, Wiendl H (2008) The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation. Hum Immunol 69: 797-804.
8. Ford ML, Evavold BD (2005) Specificity, magnitude, and kinetics of MOGspecific CD8+ T cell responses during experimental autoimmune encephalomyelitis. Eur J Immunol 35: 76-85. (Pubitemid 40123854)
9. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlen C, et al. (2001) A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 194: 669-676. (Pubitemid 32844776)
10. Ji Q, Goverman J (2007) Experimental autoimmune encephalomyelitis mediated by CD8+ T cells. Ann N Y Acad Sci 1103: 157-166. (Pubitemid 46791117)
11. Sun D, Whitaker JN, Huang Z, Liu D, Coleclough C, et al. (2001) Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 166: 7579-7587. (Pubitemid 32525639)
12. Koh DR, Fung-Leung WP, Ho A, Gray D, Acha-Orbea H, et al. (1992) Less mortality but more relapses in experimental allergic encephalomyelitis in CD82/2 mice. Science 256: 1210-1213.
13. Friese MA, Jakobsen KB, Friis L, Etzensperger R, Craner MJ, et al. (2008) Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat Med 14: 1227-1235.
14. Jiang H, Zhang SI, Pernis B (1992) Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256: 1213-1215.
15. Najafian N, Chitnis T, Salama AD, Zhu B, Benou C, et al. (2003) Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. J Clin Invest 112: 1037-1048. (Pubitemid 38056319)
16. Linker RA, Rott E, Hofstetter HH, Hanke T, Toyka KV, et al. (2005) EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHCI restricted immune responses. Neurobiol Dis 19: 218-228. (Pubitemid 40544739)
17. Jurewicz A, Biddison WE, Antel JP (1998) MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J Immunol 160: 3056-3059. (Pubitemid 28136763)
18. Anderson AC, Chandwaskar R, Lee DH, Sullivan JM, Solomon A, et al. (2012) A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells. J Immunol 188: 2084-2092.
19. Bettini M, Rosenthal K, Evavold BD (2009) Pathogenic MOG-reactive CD8+ T cells require MOG-reactive CD4+ T cells for sustained CNS inflammation during chronic EAE. J Neuroimmunol 213: 60-68.
20. Huber M, Heink S, Pagenstecher A, Reinhard K, Ritter J, et al. (2013) IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. J Clin Invest 123: 247-260.
21. Na SY, Cao Y, Toben C, Nitschke L, Stadelmann C, et al. (2008) Naive CD8 Tcells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain 131: 2353-2365.
22. Ip CW, Kroner A, Bendszus M, Leder C, Kobsar I, et al. (2006) Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J Neurosci 26: 8206-8216. (Pubitemid 44315145)
23. Kassmann CM, Lappe-Siefke C, Baes M, Brugger B, Mildner A, et al. (2007) Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 39: 969-976. (Pubitemid 47185174)
24. Ortega SB, Kashi VP, Tyler AF, Cunnusamy K, Mendoza JP, et al. (2013) The disease-ameliorating function of autoregulatory CD8 T cells is mediated by targeting of encephalitogenic CD4 T cells in experimental autoimmune encephalomyelitis. J Immunol 191: 117-126.
25. Lee YH, Ishida Y, Rifa'i M, Shi Z, Isobe K, et al. (2008) Essential role of CD8+ CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis. J Immunol 180: 825-832.
26. York NR, Mendoza JP, Ortega SB, Benagh A, Tyler AF, et al. (2010) Immune regulatory CNS-reactive CD8+ T cells in experimental autoimmune encephalomyelitis. J Autoimmun 35: 33-44.
27. Baughman EJ, Mendoza JP, Ortega SB, Ayers CL, Greenberg BM, et al. (2011) Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis. J Autoimmun 36: 115-124.
28. Yogev N, Frommer F, Lukas D, Kautz-Neu K, Karram K, et al. (2012) Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells. Immunity 37: 264-275.
29. Mildner A, Mack M, Schmidt H, Bruck W, Djukic M, et al. (2009) CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain 132: 2487-2500.
30. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM (2011) Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 14: 1142-1149.
31. Weber MS, Prod'homme T, Youssef S, Dunn SE, Rundle CD, et al. (2007) Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat Med 13: 935-943. (Pubitemid 47222047)
32. Weber MS, Prod'homme T, Patarroyo JC, Molnarfi N, Karnezis T, et al. (2010) B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol 68: 369-383.
33. Krumbholz M, Derfuss T, Hohlfeld R, Meinl E (2012) B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol 8: 613-623.
34. Molnarfi N, Schulze-Topphoff U, Weber MS, Patarroyo JC, Prod'homme T, et al. (2013) MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med 210: 2921-2937.
35. Schlitzer A, Ginhoux F (2014) Organization of the mouse and human DC network. Curr Opin Immunol 26C: 90-99.
36. Lewis KL, Reizis B (2012) Dendritic cells: arbiters of immunity and immunological tolerance. Cold Spring Harb Perspect Biol 4: a007401.
37. Gutcher I, Becher B (2007) APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 117: 1119-1127. (Pubitemid 46718396)
38. Zhou H, Wang Y, Lian Q, Yang B, Ma Y, et al. (2014) Differential IL-10 production by DCs determines the distinct adjuvant effects of LPS and PTX in EAE induction. Eur J Immunol.
39. Mangalam AK, Luckey D, Giri S, Smart M, Pease LR, et al. (2012) Two discreet subsets of CD8 T cells modulate PLP (91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice. J Autoimmun 38: 344-353.
40. Saxena A, Bauer J, Scheikl T, Zappulla J, Audebert M, et al. (2008) Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J Immunol 181: 1617-1621.
41. Mars LT, Bauer J, Gross DA, Bucciarelli F, Firat H, et al. (2007) CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice. J Immunol 179: 5090-5098.
42. Tsai S, Shameli A, Yamanouchi J, Clemente-Casares X, Wang J, et al. (2010) Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 32: 568-580.
43. Burger D, Molnarfi N, Weber MS, Brandt KJ, Benkhoucha M, et al. (2009) Glatiramer acetate increases IL-1 receptor antagonist but decreases T cellinduced IL-1beta in human monocytes and multiple sclerosis. Proc Natl Acad Sci U S A 106: 4355-4359.
44. Kala M, Rhodes SN, Piao WH, Shi FD, Campagnolo DI, et al. (2010) B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis. Exp Neurol 221: 136-145.
45. Miller SD, McMahon EJ, Schreiner B, Bailey SL (2007) Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 1103: 179-191. (Pubitemid 46791123)
46. Ji Q, Castelli L, Goverman JM (2013) MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8(+) T cells. Nat Immunol 14: 254-261.
47. Segura E, Durand M, Amigorena S (2013) Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. J Exp Med 210: 1035-1047.
48. Joffre OP, Segura E, Savina A, Amigorena S (2012) Cross-presentation by dendritic cells. Nat Rev Immunol 12: 557-569.
49. Leech MD, Barr TA, Turner DG, Brown S, O'Connor RA, et al. (2013) Cutting edge: IL-6-dependent autoimmune disease: dendritic cells as a sufficient, but transient, source. J Immunol 190: 881-885.
50. Shaw PJ, Barr MJ, Lukens JR, McGargill MA, Chi H, et al. (2011) Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity. Immunity 34: 75-84.
51. Bailey-Bucktrout SL, Caulkins SC, Goings G, Fischer JA, Dzionek A, et al. (2008) Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J Immunol 180: 6457-6461.
52. Deshpande P, King IL, Segal BM (2007) Cutting edge: CNS CD11c+ cells from mice with encephalomyelitis polarize Th17 cells and support CD25+CD4 + T cell-mediated immunosuppression, suggesting dual roles in the disease process. J Immunol 178: 6695-6699. (Pubitemid 46847389)
53. Sinha S, Itani FR, Karandikar NJ (2014) Immune regulation of multiple sclerosis by CD8+ T cells. Immunol Res.
54. Saraiva M, O'Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170-181.
55. Demangel C, Bertolino P, Britton WJ (2002) Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur J Immunol 32: 994-1002. (Pubitemid 34428814)
56. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, et al. (2003) Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617. (Pubitemid 36588578)
57. Gonzalez P, Burgaya F, Acarin L, Peluffo H, Castellano B, et al. (2009) Interleukin-10 and interleukin-10 receptor-I are upregulated in glial cells after an excitotoxic injury to the postnatal rat brain. J Neuropathol Exp Neurol 68: 391-403.
58. Knoblach SM, Faden AI (1998) Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol 153: 143-151. (Pubitemid 28452306)